Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma. | Clin Res Hepatol Gastroenterol | 2022 | 35151910 | PubTator, text mining | PubMed |
| The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology. | BMC Med | 2022 | 35151316 | PubTator, text mining | PubMed |
| Prediction of breast cancer risk based on flow variant analysis of circulating peripheral blood mononuclear cells. | HGG Adv | 2022 | 35146455 | PubTator, text mining | PubMed |
| Aberrant epigenetic and transcriptional events associated with breast cancer risk. | Clin Epigenetics | 2022 | 35139887 | PubTator, text mining | PubMed |
| Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. | J Exp Clin Cancer Res | 2022 | 35139879 | PubTator, text mining | PubMed |
| Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2022 | 35138920 | PubTator, text mining | PubMed |
| PROFOUND trial -a new era in targeted therapeutics for prostate carcinoma. | Indian J Urol | 2022 | 35136301 | PubTator, text mining | PubMed |
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer. | Breast | 2022 | 35124320 | PubTator, text mining | PubMed |
| Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study. | Dig Dis Sci | 2022 | 35122589 | PubTator, text mining | PubMed |
| Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma. | Ann Gastroenterol Surg | 2022 | 35106410 | PubTator, text mining | PubMed |
| Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer. | Mol Genet Genomic Med | 2022 | 35084806 | PubTator, text mining | PubMed |
| Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 | 35084436 | PubTator, text mining | PubMed |
| Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. | Nat Commun | 2022 | 35082299 | PubTator, text mining | PubMed |
| DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. | JNCI Cancer Spectr | 2022 | 35079693 | PubTator, text mining | PubMed |
| Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing. | Ann Oncol | 2022 | 35074424 | PubTator, text mining | PubMed |
| Pathogenesis of Triple-Negative Breast Cancer. | Annu Rev Pathol | 2022 | 35073169 | PubTator, text mining | PubMed |
| Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer. | J Cancer | 2022 | 35069909 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis. | BMC Musculoskelet Disord | 2022 | 35057767 | PubTator, text mining | PubMed |
| Harnessing Synthetic Lethal Interactions for Personalized Medicine. | J Pers Med | 2022 | 35055413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=61